|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
ABSTRACT |
|---|
|
|
|---|
Primary sensitization to antigens may occur prenatally. We hypothesized that high prenatal exposure to indoor antigens increases the risk for sensitization in newborns in New York City populations with increased risk for asthma. We also investigated whether maternal sensitization is required for in utero sensitization to occur. One hundred sixty-seven pregnant African American or Dominican women residing in northern Manhattan were recruited and antigen was measured from home dust. After delivery, newborn cord and maternal blood were assayed for IgE and mononuclear cell proliferation and cytokine production in response to antigen. Cockroach, mouse, but not dust mite antigens, were commonly elevated in the kitchens and pregnant mothers' beds. Increased mononuclear cell proliferation occurred in 54% of newborns in response to cockroach, 25% in response to dust mite Dermatophagoides pteronyssinus, 40% in response to dust mite D. farinae, and 34% in response to mouse protein extracts. Antigen-induced mononuclear cell proliferation occurred in cord blood even in the absence of antigen-induced mononuclear cell proliferation in the mother. Proliferation in response to antigens did not correlate with IgE levels, but proliferation in response to dust mite extracts correlated with interluekin-5 (IL-5) production in cord blood. These results suggest that (1) high prenatal exposures to cockroach and mouse antigens are prevalent; (2) in utero sensitization to multiple indoor antigens is common, occurs to a different degree than maternal sensitization, and may involve IL-5 upregulation.
| |
INTRODUCTION |
|---|
|
|
|---|
Keywords: in utero sensitization; indoor antigens; lymphocyte proliferation
Asthma morbidity and mortality have increased significantly in the United States since the late 1970s (1, 2). The most substantial increases have occurred among children zero to 4 yr of age (1) and among urban ethnic minorities (1, 3). These ethnic disparities are prominent in New York City (NYC), where hospitalization and death rates from asthma are as much as five times greater among non-Latino African Americans and Latinos than among non-Latino white individuals (2).
Exposure to dust mite allergen has been shown to increase the risk for the onset of asthma (4), and reductions of dust mite allergen have been shown to reduce asthma morbidity (5). Although exposure to several other indoor allergens or antigens (i.e., derived from cats, dogs, and fungi) has been hypothesized to contribute to the development of asthma, exposure and sensitization to cockroach antigens has emerged as playing a significant role in several U.S. inner cities (6, 7). High levels of cockroach antigen in apartments housing children 3 mo of age born to asthmatic/allergic parents increased the risk of repeated wheezing episodes by 1 yr of age (8), and increased T-cell reactivity in response to cockroach antigen at 2 yr of age (9). Moreover, children with elevated total serum immunoglobulin E (IgE) levels at 9 mo of age were predisposed to persistent wheezing and positive allergy skin tests by 6 yr of age (10), suggesting that critical exposures to antigens may occur at a very young age.
Prenatal antigen exposure may lead to sensitization in the newborn. Very low levels of total IgE have been measured at birth, yet their presence does not predict persistent wheezing during childhood (11). Instead, studies have utilized cord blood mononuclear cell (CBMC) proliferation assays for T-cell reactivity in response to specific antigens as a surrogate measure for sensitization. In adults, such proliferation assays reflected T-cell responses (12), and in the case of dust mite proteins, correlated with skin test sensitivity (13). Thus far cord blood mononuclear cells have been shown to proliferate after in vitro stimulation to tree, grass, birch, cat, and dust mite antigens (14, 15). Dust mite and ovalbumin-specific T-cell clones have been derived from cord blood. Genotyping has demonstrated that these antigen-specific clones are fetal in origin (16).
These results suggest that sensitization and the development of T-cell memory may occur prenatally. The prevalence of in utero sensitization to indoor antigens, predisposing factors, and mechanism and eventual clinical relevance is not known. We hypothesized that high exposure to indoor antigens during the prenatal period in NYC populations with increased asthma morbidity rates is important to antigen sensitization in newborns. We also investigated whether CBMC proliferation in response to antigens occurs even in the absence of maternal sensitization.
| |
METHODS |
|---|
|
|
|---|
Patients
The cohort consisted of 167 pregnant women, self-reported as African American or Dominican and residing in Harlem, Washington Heights, or the South Bronx of NYC. Over 19 mo pregnant women were recruited from clinics affiliated with Columbia University as part of an ongoing study under the auspices of the Columbia Center for Children's Environmental Health. Exclusion criteria for women included smoking, illicit drug use, diabetes, hypertension, HIV infection, younger than 18 or older than 35 yr of age, and residence in New York City for less than 1 yr prior to pregnancy. The study was approved by the Institutional Review Board, and written informed consent was obtained from all participants.
Dust Collection, Antigen Measurement, and Blood Collection
Dust samples from a subset of 74 homes during the first 12 mo of recruitment were analyzed for inhalant antigens in the approximate order they were enrolled. Most samples were collected prenatally (n = 68; mean, 43 d; range, 3 to 82 d prepartum), and six were collected postpartum (mean, 26 d; range, 4 to 82 d). Dust samples were vacuumed separately from the kitchen and pregnant mother's bed (17). Mouse urinary protein was assayed with a competitive enzyme-linked immunosorbent assay (ELISA) using a mouse urine mixture (containing Mus m 1), a polyclonal antibody (rabbit antimouse) (Greer Laboratories, Inc., Lenoir, NC), and a polyclonal goat antirabbit antibody (Sigma Chemical Co., St Louis, MO). Dust mite (Der f 1 and Der p 1) and cockroach antigens (Bla g 2) were assayed by ELISA (Indoor Biotechnologies, Clwyd, UK) (18).
Cord blood was collected at delivery and maternal blood within 1 d postpartum. Fresh mononuclear blood cells were separated by density centrifugation (19) and plated in triplicate for proliferation assays and in duplicate for cytokine assays. In 12 cases, insufficient blood was obtained for mononuclear cell isolation.
Proliferation, IgE, and Cytokine Assays
Mononuclear cells were cultured in microtiter plates as described (13, 15). Cells were cultured for 5 d with phytohemagglutinin (PHA) positive control (10 µg/ml) (Sigma), German cockroach (10 µg/ml), Dermatophagoides pteronyssinus (10 µg/ml), D. farinae (10 µg/ml), mouse protein extract (10 µg/ml) (Greer Laboratories), and tetanus toxoid (1:500 dilution) (Wyeth-Lederle Vaccines and Pediatrics, Pearl River, NY) or no antigen. T-cell reactivity in response to D. pteronyssinus protein extracts (Greer Laboratories) with that in response to monoclonal affinity-purified Der p 1 and Der p 2 proteins (10 µg/ml) (kindly furnished by Martin Chapman, University of Virginia) in subset of cord (n = 51) and maternal (n = 57) specimens also was compared. Proliferation was measured by thymidine incorporation (20). Increased proliferation in response to antigen was defined as (1) Stimulation Index (SI) (averaged counts per minute [cpm] in the presence of antigen divided by averaged cpm without antigen) greater than 2, and (2) antigen-induced averaged cpm greater than 1,000 above background (14, 15). A separate aliquot of 3 × 105 cells/well was cultured simultaneously with PHA, cockroach, dust mite, mouse extract, or no antigen under identical conditions, and supernatants were collected on Day 5 for cytokine analysis.
Total serum levels were measured by immunoradiometric assay
(Total IgE IRMA; Diagnostics Products Corp., Los Angeles, CA). Allergen-specific IgE levels were measured by the Fluorescence Allergosorbent Test (FAST) (BioWhittaker, Walkersville, MD) (21). Interleukin-5 (IL-5) and interferon gamma (IFN-
) levels from culture supernatants were measured by ELISA (Immunotech, Marseille, France). All specimens were analyzed in duplicate.
Statistical Analysis
Nonparametric statistical analyses were performed as described (22), except where noted. Levene's test for equality of variance was utilized to determine the appropriate form of t test prior to parametric testing. Exposure/biomarker relationships were assessed by categorizing the dustborne antigen into four groups (below detectable limits, 0 to 2, 2 to 8, > 8 µg or Ug/g) and performing ANOVA for trends (SPSS statistical software, Chicago, IL). Comparisons between proliferation in response to D. pteronyssinus protein extract (containing Der p 1 and Der p 2 proteins) and purified Der p 1 or Der p 2 protein were made as described (see Appendix ).
| |
RESULTS |
|---|
|
|
|---|
Characteristics of the study population are shown in Table 1. Cockroach and mouse antigen was commonly recovered from kitchen samples and, to a lesser extent, the pregnant mother's bed (Figure 1, top and middle panels). Der f 1 and Der p 1 were below 2 µg/g dust in 99 and 93% of the beds, respectively (Figure 1, bottom panel).
|
|
Mononuclear Cell Proliferation and Cytokine Production in Response to Indoor Antigens
The SI was increased in 54% of newborns in response to cockroach extract, 25% in response to D. pteronyssinus extract, 40% in response to D. farinae extract, 34% in response to mouse extract, and 3% in response to tetanus toxoid (Figure 2). We observed a high degree of correlation between the T-cell proliferation in response to the two dust mite species (Spearman's rho, r = 0.581; p < 0.001), possibly in part reflecting their extensive cross-reactivity (23). Because sensitization to tetanus only occurs in offspring of mothers immunized during pregnancy (24), our finding that cord blood proliferation was significantly more common to all tested antigens than to tetanus (p < 0.0005, McNemar Test) supports the likelihood that nonspecific T-cell reactivity and significant maternal blood contamination are not present. In addition, cord blood proliferation in response to cockroach, D. farinae (p < 0.0005), and mouse (p < 0.05) extract was significantly more frequent than in response to D. pteronyssinus extract, the protein associated with the lowest level of detectable exposure in the homes. As a control for possible nonspecific mitogenic effects of the protein extracts (12, 13), we found significant correlations between T-cell reactivity in response to D. pteronyssinus protein extract with that observed in response to monoclonal purified Der p1 (n = 49, Spearman's rho, r = 0.659; p value < 0.0005) and Der p 2 protein (n = 39, Spearman's rho, r = 0.432; p value < 0.01). This result implies that the neonatal T-cell reactivity occurred in specific response to dust mite antigen.
|
Increased maternal blood mononuclear cell proliferation was seen in 43% in response to cockroach extract, 60% in response to D. pteronyssinus extract, 65% in response to D. farinae extract, 30% in response to mouse extract, and 41% in response to tetanus toxoid (Figure 3). Similar to our observations in newborns, T-cell reactivity in response to indoor antigens was common, and strong correlations were found between the D. pteronyssinus and D. farinae extract-induced responses (Spearman's rho, r = 0.798; p < 0.0005). In addition, proliferation in response to D. pteronyssinus protein extract correlated significantly with that obtained in response to monoclonal purified Der p1 (n = 56, Spearman's rho, r = 0.509; p value < 0.0005) and Der p 2 protein (n = 48, Spearman's rho, r = 0.334; p value < 0.05). The mean SI in response to D. pteronyssinus extract, D. farinae extract, and tetanus was significantly greater (p < 0.0005, t test for comparison of means) than that observed in newborns. Finally, a reported history of tetanus immunization within the previous 10 yr was associated with tetanus-induced T-cell reactivity in the mothers (Fisher's exact test, two-tailed p < 0.05).
|
We found no significant correlation between either cord- or maternal-total IgE and proliferation in response to any individual or group of antigens (data not shown). Although allergen-specific IgE was not measurable in cord blood, cockroach and dust mite-specific IgE levels in maternal blood were only weakly associated with proliferation in response to the same antigen (r = 0.194, p = 0.035; r = 0.177, p = 0.056; respectively). These results suggest that while T-cell reactivity in response to indoor antigens may represent a biomarker for exposure, it may not necessarily signify an IgE-mediated allergic response.
To distinguish whether T-cell proliferation in response to antigens reflects an allergic response or a T-cell-mediated immune response to a previous exposure, we compared newborn T
helper 2 (i.e., IL-5) cytokine production in response to antigen
stimulation with T helper 1 (i.e., IFN-
) levels. The median
IL-5 level after cord blood stimulation with PHA, cockroach
extract, dust mite extract, and mouse extract was significantly
greater than that observed in the absence of stimulation with
antigen. Similar increases in the median IFN-
levels were observed in response to PHA, cockroach extract, and D. farinae
extract (Tables 2A and 2B). Increased IL-5 (Tables 3A and 3C)
and less consistently IFN-
(Tables 3B and 3D) production in
specific association with increased T-cell proliferation was observed only after stimulation with dust mite extract, suggesting
that allergic cytokine responses occur only in restricted cases.
|
|
|
|
|
|
Relationship between Antigen-induced Proliferation and Indoor Antigen Levels
Seasonally dependent cord blood reactivity in response to outdoor allergens has been described (25), suggesting that a relationship between prenatal environmental exposure and sensitization may exist. We found no significant association, however, between cockroach antigen levels in the kitchen or pregnant mother's bed and cockroach extract-induced proliferation and cockroach-specific IgE in either maternal or cord blood (data not shown). Similarly, such associations were absent for dust mite antigen in settled dust and maternal and cord blood biomarkers. In contrast, increased maternal, but not cord blood, lymphocyte proliferative responses to mouse extract was associated with higher levels of mouse antigen in kitchen dust (for trend, p < 0.05). In particular, mouse antigen levels greater than 3 µg/g dust in the kitchen were associated with increased maternal T-cell reactivity to mouse extract (mean SI, 1.58 ± 0.89 < 3 µg/g dust versus mean SI 2.95 ± 1.82 > 3 µg/g dust, t test for equality of means, p < 0.05).
Relationship between Parental Atopy, Maternal Sensitization, and in Utero Sensitization
We found no relationship between history of atopy or asthma in the parent and the presence of any biomarker in the cord blood, including IgE level and antigen-induced proliferation (data not shown). Maternal total IgE level and cord blood total IgE level weakly correlated (r = 0.220; p value < 0.05). In addition, maternal allergen-specific IgE levels to cockroach, D. farinae, and mouse did not correlate with cord blood proliferation in response to the same antigen (data not shown). These results suggest that maternal allergic responses to cockroach, dust mite, and mouse proteins may not confer an increased risk for prenatal sensitization to these antigens.
To assess whether antigen-induced T-cell reactivity in the newborn may develop in the absence of antigen-induced T-cell reactivity in the mother, we also compared the same mononuclear cell proliferation assay for sensitization in both mothers and newborns. We found that for cockroach extract, dust mite extract, and tetanus, the presence of proliferation in response to antigen significantly differed between mothers and newborns (Table 4). In many cases, antigen-induced proliferation occurred in cord blood in the absence of antigen-induced proliferation in maternal blood. This finding was more common in response to cockroach (30% of cases) and mouse (24% of cases) extract. These results suggest that in utero sensitization can occur in the absence of sensitization within the mother.
|
| |
DISCUSSION |
|---|
|
|
|---|
We found that T-cell reactivity occurred in cord blood in response to multiple indoor antigens, including cockroach and mouse antigen. These findings suggest that in utero sensitization to indoor antigens is frequent in a population where asthma morbidity is common (2). T-cell reactivity in response to cockroach and mouse antigen also occurred frequently in a population where environmental exposure to these antigens is prevalent and often ranged well above thresholds previously associated with sensitization (26, 27). Because sensitization to dust mite can occur at levels of exposure less than 2 µg/g dust (28), the low levels measured here may be sufficient for an immune response to develop.
Several observations strongly suggest that the T-cell reactivity we are reporting is antigen-specific. First, the proliferative responses to dust mite protein extracts and highly purified Der p 1 and 2 proteins correlated in both cord and maternal blood. Second, T-cell reactivity in cord blood occurred more often to allergens than in response to tetanus toxoid. Finally, cord blood T-cell proliferation occurred significantly more frequently in response to the antigens commonly measured in the apartments than to the rarely detected D. pteronyssinus proteins.
The absence of a strong association between T-cell proliferation and allergen-specific IgE levels, as well as the lack of correlation between IL-5 production and T-cell reactivity beyond what we observed after dust mite stimulation, implies that T-cell reactivity is not equivalent to an allergic immune response. An alternative explanation of our results is that the IL-5 upregulation may reflect increased Th2 cytokine production previously reported to occur at the maternal-fetal interface (29). In this milieu, increased placental production of Th2 cytokines may promote in utero sensitization by inducing further Th2 proliferation and differentiation as well as upregulating IL-4 mediated MHC II expression (30).
Although the level of mouse antigen measured in settled dust was associated with increased maternal T-cell reactivity in response to mouse extract, this relationship was absent for cockroach and dust mite extract. On the basis of previous reports on levels of dust mite antigen (31), we believe that the bed sample reflects an antigen level that would be correlated with other areas within a pregnant mother's home. However, antigen content in settled dust is only a surrogate for the actual amount of antigen inhaled into the pregnant mother's lungs. It is likely to be an unreliable measure of the biologically effective dose that reaches the fetus. Other unmeasured sources of antigen exposure exist from movable objects such as blankets and exposures outside the home (32). In addition, proteins not measured in our assay (Der f 2, Bla g 4) may be important. Moreover, host susceptibility (i.e., genetic factors), including MHC class II restriction, contributes to the amount of antigen processed and the subsequent development of sensitization. For example, different HLA-DR and DQ genes have been associated with altered dust mite antigen recognition by T cells (33) and dust mite-IgE production (34).
Our observation that cord blood lymphoproliferation can occur more often than maternal lymphoproliferation, and even in its absence, implies that the immune response may be occurring in the placenta. One explanation is that some amount of the relevant antigen, to which the mother is exposed during pregnancy, reaches the placenta where antigen presentation occurs. In support of this hypothesis, antigen-presenting cells (APCs) have been detected in the placenta in increasing numbers during pregnancy. These include dendritic cells that express MHC class II antigens (35) and are efficient in facilitating antigen-induced T-cell proliferative responses (36). Cord blood T cells can be activated via their T-cell receptor (TCR) and express normal levels of CD28, LFA-1, CD40 ligand, and CD25 (37). Cord blood B cells can undergo isotype class switching to IgE and IgG4 (37, 38). Alternately, the antigens may reach the placenta as IgG-complexed antigens or anti-idiotypic antibodies that have already undergone antigen processing and subsequently sensitize the fetus (39, 40).
Although antigen-induced T-cell proliferation may be a biomarker for antigen exposure, its ability to predict which individuals will develop a subsequent allergic immune response is not known. One group examined the end points of asthma and allergic rhinitis at 12 and at 24 mo of age, even though such diagnoses are difficult at these ages (11), and found they were not associated with increased cord blood proliferation in response to dust mite antigen (20). Another possibility is that Th2 cytokine upregulation in association with T-cell reactivity and/or environmental antigen exposure may predict future atopy. Helminth-specific Th2 upregulation in utero was maintained until 10 to 14 mo of age and associated with diminished BCG responses (41), implying that these neonatal patterns may persist and have clinical significance. Prospective study of this cohort will help address the clinical significance of cord blood lymphoproliferation in response to indoor antigens, and help evaluate which biomarkers may identify an individual at increased risk for developing allergic immune responses, including asthma.
| |
Footnotes |
|---|
Correspondence and requests for reprints should be addressed to Rachel L. Miller, M.D., PH8C, Columbia University College of Physicians and Surgeons, 630 W. 168th St, New York, New York 10032. E-mail: rlm14{at}columbia.edu
(Received in original form November 22, 2000 and in revised form June 8, 2001).
This article has an online data supplement, which is accessible from this issue's table of contents online at www.atsjournals.orgAcknowledgments: The authors thank Paul Rothman for his guidance, helpful discussion, and critical reading of the manuscript. They thank Joanna Jerzynska and Sally Wenzel for their critical review of the manuscript. They also appreciate Martin Chapman's generous donation of the purified Der p proteins. They are indebted to Howard Andrews, Lori Hoepner, Kristin Wendt, Robin Garfinkel, Jessica Dietrich, Tara Gingrich, Judy Ramirez, Andria Reyes, Diurka Diaz, Elizabeth Kelvin, Gabor Halasz, Guellue Cataldegirmen, Rosenda Mizuno, Louis Calderon, Darrell Holmes, Kwami Boatang, Eric Evans, Mejico Borjas, and George Betances for their assistance in the conduct of this study.
Supported by Grants No. P50 ES09600, and No. 5 R01 ES08977 from the National Institute of Environmental Health Sciences, by Grant No. R827027 from the Environmental Protection Agency, by Grant no. RR00645 from the General Clinical Research Center, and by the Bauman Family Foundation, the Gladys and Roland Harriman Foundation, the W. Alton Jones Foundation, the New York Community Trust, and the Robert Wood Johnson Foundation.
| |
References |
|---|
|
|
|---|
1. CDC Surveillance Summaries. In: Surveillance for Asthma-United States, 1960-1995. Atlanta, Georgia: Centers for Disease Control and Prevention; 1998:i-28.
2. Carr W, Zeitel L, Weiss K. Variations in asthma hospitalizations and deaths in New York City. Am J Public Health 1992; 82: 58-65 .
3. Grant EN, Wagner R, Weiss KB. Observations on emerging patterns of asthma in our society. J Allergy Clin Immunol 1999; 104: S1-9 [Medline].
4. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ. Exposure to house-dust mite allergen (Der p 1) and the development of asthma in childhood. A prospective study. N Engl J Med 1990; 323: 502-507 [Abstract].
5. Harving H, Korsgaard J, Dahl R. Clinical efficacy of reduction in house-dust mite exposure in specially designed, mechanically ventilated "healthy" homes. Allergy 1994; 49: 866-870 [Medline].
6.
Rosenstreich DL,
Eggleston P,
Kattan M,
Baker D,
Slavin RG,
Gergen P,
Mitchell H,
McNiff-Mortimer K,
Lynn H,
Ownby D, et al
.
. The role
of cockroach allergy and exposure to cockroach allergen in causing
morbidity among inner-city children with asthma.
N Engl J Med
1997;
336:
1356-1363
7.
Platts-Mills TAE,
Carter MC.
Asthma and indoor exposure to allergens.
N Engl J. Med
1997;
336:
1382-1384
8.
Gold DR,
Burge HA,
Carey V,
Milton DK,
Platts-Mills T,
Weiss ST.
Predictors of repeated wheeze in the first year of life: the relative roles
of cockroach, birthweight, acute lower respiratory illness, and maternal smoking.
Am J Respir Crit Care Med
1999;
160:
227-236
9. Finn PW, Boudreau JO, He H, Chapman M, Vincent C, Burge HA, Weiss ST, Perkins DL, Gold DR. Children at risk for asthma: home allergen levels, lymphocyte proliferation, and wheeze. J Allergy Clin Immunol 2000; 105: 933-942 [Medline].
10. Sherill DL, Stein R, Halonen M, Holberg CJ, Wright A, Martinez FD. Total serum IgE and its association with asthma symptoms and allergic sensitization among children. J Allergy Clin Immunol 1999; 104: 28-36 [Medline].
11.
Martinez FD,
Wright AL,
Taussig LM,
Holberg CJ,
Halonen M,
Morgan WJ.
Asthma and wheezing in the first six years of life.
N Engl J Med
1995;
332:
133-138
12. Rawle FC, Mitchell EB, Platts-Mills TAE. T cell responses to the major allergen from the house dust mite Dermatophagoides pteronyssinus, antigen P1: comparison of patients with asthma, atopic dermatitis, and perennial rhinitis. J Immunol 1984; 133: 195-201 [Abstract].
13. Obrien RM, Thomas WR, Wootton AM. T cell responses to the purified major allergens from the house dust mite Dermatophagoides pteronyssinus. J Allergy Clin Immunol 1992; 89: 1021-1031 .
14. Miles EA, Warner JA, Jones AC, Colwell BM, Bryant TN, Warner JO. Peripheral blood mononuclear cell proliferative responses in the first year of life in babies born to allergic parents. Clin Exp Allergy 1996; 26: 780-788 [Medline].
15. Prescott SL, Macaubas C, Yabuhara A, Venaille TJ, Holt BJ, Habre W, Loh R, Sly PD, Holt PG. Developing patterns of T cell memory to environmental allergens in the first two years of life. Int Arch Allergy Immunol 1997; 113: 75-79 [Medline].
16.
Prescott SL,
Macaubas C,
Holt BJ,
Smallacombe TB,
Loh R,
Sly PD,
Holt PG.
Transplacental priming of the human immune system to environmental allergens: universal skewing of initial T cell responses toward the Th2 cytokine profile.
J Immunol
1998;
160:
4730-4737
17. Strien RT, Verhoeff AP, Brunekreef B, Wijnen JH. Mite antigen in house dust: relationship with different housing characteristics in the Netherlands. Clin Exp Allergy 1994; 24: 843-853 [Medline].
18. Pollart SM, Smith TF, Morris EC, Gelber LE, Platts-Mills TAE, Chapman MD. Environmental exposure to cockroach allergens: analysis with monoclonal antibody-based enzyme immunoassays. J Allergy Clin Immunol 1991; 87: 505-510 [Medline].
19. Boyum A. Isolation of mononuclear cells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968; 97: 77-89 [Medline].
20. Chan-Yeung M, Ferguson A, Chan H, Dimich-Ward H, Watson W, Manfreda J, Becker A. Umbilical cord blood mononuclear cell proliferative response to house dust mite does not predict the development of allergic rhinitis and asthma. J Allergy Clin Immunol 1999; 104: 317-321 [Medline].
21. Wu C-H, Wang NM, Lee M-F, Kao C-YY, Luo S-F. Cloning of the American cockroach CR-PII allergens: evidence for the existence of cross-reactive allergens between species. J Allergy Clin Immunol 1998; 101: 832-840 [Medline].
22. Fleiss JL. The design and analysis of clinical experiments. New York City: John Wiley and Sons; 1986.
23. Heymann PW, Chapman MD, Platts-Mills TA. Antigen Der f 1 from the dust mite Dermatophagoides farinae: Structural comparison with Der p 1 from Dermatophagoides pteronyssinus and epitope specificity of murine IgG and human IgE antibodies. J Immunol 1986; 137: 2841-2847 [Abstract].
24. Gill TJI, Repetti CF, Metlay LA, Rabin BS, Taylor FH, Thompson DS, Cortese AL. Transplacental immunization of the human fetus to tetanus by immunization of the mother. J Clin Invest 1983; 72: 987-996 .
25. Piccini MP, Mecacci F, Sampognaro S, Manetti R, Parronchi P, Maggi E, Romagnani S. Aeroallergen sensitization can occur during fetal life. Int Arch Allergy Immunol 1993; 102: 301-303 [Medline].
26. Eggleston PA, Rosenstreich D, Lynn H, Gergen O, Baker D, Kattan M, Mortimer KM, Mitchell H, Ownby D, Slavin R, et al . . Relationship of indoor allergen exposure to skin test sensitivity in inner-city children with asthma. J Allergy Clin Immunol 1998; 102: 563-570 [Medline].
27. Phipatanakul W, Eggleston PA, Wright EC, Wood RA. Risk factors for sensitization to mouse allergen in inner-city children with asthma. J Allergy Clin Immunol 2000; 105: S79 .
28. Munir AKM. Risk levels for mite allergen: are they meaningful, where should samples be collected, and how should they be analyzed? Allergy 1998;53(Suppl 48):84-87.
29. Lin H, Mosmann TR, Guilbert L, Tuntipopipat S, Wegmann TG. Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J Immunol 1993; 151: 4562-4573 [Abstract].
30.
Noelle R,
Krammer PH,
Ohara J,
Uhr JW,
Vitetta ES.
Increased expression of Ia antigens on resting B cells: an additional role for B-cell
growth factor.
Proc Natl Acad Sci USA
1984;
81:
6149-6153
31. Strien RTV, Verhoeff AP, Wijnen JHV, Doekes G, Meer GEAD, Brunekreef B. Der p 1 concentrations in mattress surface and floor dust collected from infants' bedrooms. Clin Exp Allergy 1995; 25: 1184-1189 [Medline].
32. Wickens K, Martin I, Pearce N, Fitzharris P, Kent R, Holbrook N. House dust mite allergen levels in public places in New Zealand. J Allergy Clin Immunol 1997; 99: 587-593 [Medline].
33.
O'Hehir RE,
Lamb JR.
Direct evidence for a functional role of HLA-DRB1 and anti-DRB3 gene products in the recognition of Dermatophagoides spp (house dust mite) by helper T lymphocytes.
Int
Immunol
1990;
2:
885-892
34. Stephan V, Kuehr J, Seibt A, Saueressig H, Zingsem S, Dinh TD, Moseler M, Wahn V, Deichmann KA. Genetic linkage of HLA-class II locus to mite-specific IgE immune responsiveness. Clin Exp Allergy 1999; 29: 1049-1054 [Medline].
35.
Sorg RV,
Kogler G,
Wernet P.
Identification of cord blood dendritic
cells as an immature CD11c- population.
Blood
1999;
93:
2302-2307
36. Mizuno M, Aoki K, Kimbara T. Functions of macrophages in human decidual tissue in early pregnancy. Am J Reprod Immunol 1994; 31: 180-188 .
37. Roncarolo M-G, Bigler M, Ciuti E, Martino S, Tovo P-A. Immune responses by cord blood cells. Blood Cells 1994; 20: 573-586 [Medline].
38.
Schroeder H,
Lima J,
Zhang L,
Dasanayake A,
Philips J,
Atkinson TP.
Ontogeny of IgE and Fc
RII expression in humans.
J Allergy Clin Immunol
2000;
105:
S164
.
39. Holt PG, O'Keeffe PO, Holt BJ, Uphan JW, Baron-Hay MJ, Suphioglu C, Knox B, Stewart GA, Thomas WR, Sly PD. T-cell "priming" against environmental allergens in human neonates: sequential deletion of food antigen reactivity during infancy with concomitant expansion of responses to ubiquitous inhalant allergens. Pediatr Allergy Immunol 1995; 6: 85-90 [Medline].
40. Eloi-Santos SM, Novato-Silva E, Maselli VM, Gazzinelli G, Colley DG, Correa-Oliveira R. Idiotypic sensitization in utero of children born to mothers with schistosomiasis or Chagas disease. J Clin Invest 1989; 84: 1028-1031 .
41.
Malhotra I,
Mungai P,
Wamachi A,
Kioko J,
Ouma JH,
Kazura JW,
King CL.
Helminth- and bacillus-calmette-guerin-induced immunity
in children sensitized in utero to filariasis and schistosomiasis.
J Immunol
1999;
162:
6843-6848
| |
APPENDIX |
|---|
Comparisons between proliferation in response to D. pteronyssinus protein extract (containing Der p 1 and Der p 2 proteins) and purified Der p 1 protein were made by excluding subjects (n = 2 cord blood, n = 1 maternal blood) with a positive SI to Der p 2 but not to Der p 1 protein. Comparisons between proliferation in response to D. pteronyssinus extract and purified Der p 2 protein were made by excluding subjects (n = 10 cord blood, n = 6 maternal blood) with a positive SI to Der p 1 but not to Der p 2 protein.
This article has been cited by other articles:
![]() |
A. Bjerg, L. Hedman, M. S. Perzanowski, T. Platts-Mills, B. Lundback, and E. Ronmark Family History of Asthma and Atopy: In-depth Analyses of the Impact on Asthma and Wheeze in 7- to 8-Year-Old Children Pediatrics, October 1, 2007; 120(4): 741 - 748. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. PERERA, S. VISWANATHAN, R. WHYATT, D. TANG, R. L MILLER, and V. RAUH Children's Environmental Health Research--Highlights from the Columbia Center for Children's Environmental Health. Ann. N.Y. Acad. Sci., September 1, 2006; 1076: 15 - 28. [Abstract] [Full Text] [PDF] |
||||
![]() |
L L Magnusson, H Wennborg, J P Bonde, and J Olsen Wheezing, asthma, hay fever, and atopic eczema in relation to maternal occupations in pregnancy Occup. Environ. Med., September 1, 2006; 63(9): 640 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. A. M. Schonberger, E. Dompeling, J. A. Knottnerus, T. Maas, J. W. M. Muris, C. van Weel, and C. P. van Schayck The PREVASC study: the clinical effect of a multifaceted educational intervention to prevent childhood asthma Eur. Respir. J., April 1, 2005; 25(4): 660 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Cole Johnson, D. R. Ownby, E. M. Zoratti, S. Hensley Alford, L. K. Williams, and C. L. M. Joseph Environmental Epidemiology of Pediatric Asthma and Allergy Epidemiol. Rev., December 1, 2002; 24(2): 154 - 175. [Full Text] [PDF] |
||||
![]() |
M. B. Bracken, K. Belanger, W. O. Cookson, E. Triche, D. C. Christiani, and B. P. Leaderer Genetic and Perinatal Risk Factors for Asthma Onset and Severity: A Review and Theoretical Analysis Epidemiol. Rev., December 1, 2002; 24(2): 176 - 189. [Full Text] [PDF] |
||||
![]() |
J. Douwes and N. Pearce Asthma and the westernization 'package' Int. J. Epidemiol., December 1, 2002; 31(6): 1098 - 1102. [Full Text] [PDF] |
||||
![]() |
M. J. TOBIN Pediatrics, Surfactant, and Cystic Fibrosis in AJRCCM 2001 Am. J. Respir. Crit. Care Med., March 1, 2002; 165(5): 619 - 630. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |